Monsanto PT Raised to $145.00 (MON)
Susquehanna increased their price objective on shares of Monsanto (NYSE:MON) from $128.00 to $145.00 in a research note issued on Monday, StockRatingsNetwork.com reports. Susquehanna’s target price would suggest a potential upside of 24.62% from the company’s current price.
Shares of Monsanto (NYSE:MON) opened at 116.35 on Monday. Monsanto has a 52-week low of $94.00 and a 52-week high of $117.50. The stock’s 50-day moving average is $112. and its 200-day moving average is $104.8. The company has a market cap of $61.181 billion and a P/E ratio of 25.28.
The company also recently announced a quarterly dividend, which is scheduled for Friday, January 31st. Shareholders of record on Friday, January 10th will be paid a dividend of 0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.48%. The ex-dividend date is Wednesday, January 8th.
Several other analysts have also recently commented on the stock. Analysts at UBS AG raised their price target on shares of Monsanto from $110.00 to $118.00 in a research note to investors on Monday, November 11th. They now have a “buy” rating on the stock. Separately, analysts at Jefferson Research downgraded shares of Monsanto from a “hold” rating to a “sell” rating in a research note to investors on Tuesday, October 29th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Monsanto in a research note to investors on Tuesday, October 8th. They now have a $110.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $117.58.
Monsanto Company (NYSE:MON), along with its subsidiaries, is a provider of agricultural products for farmers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.